Iteos Therapeutics, Inc. (ITOS) Stock Leaping Forward in Aftermarket, Here’s the Reason
Iteos Therapeutics, Inc. (ITOS), a clinical-stage biopharmaceutical company, has surged 6.94% in aftermarket trading session. Consequently, ITOS stock is trading at $49.79 at the time of the writing. The surge could be attributed to the announcement of ITOS addition to S&P SmallCap 600. On Friday, ITOS closed the day at $46.56 after declining 2.49% during […]
